Trans-Clopenthixol

• Description :

  Trans-Clopenthixol ((E) -Clopenthixol) is an antibiotic, without neuroleptic effect. trans-Clopenthixol can be used to inhibit Pseudomonas aeruginosa and Plasmodium falciparum in vitro[1][2].

• Product Name Alternative :

  (E) -Clopenthixol

• UNSPSC :

  12352005

• Target :

  Antibiotic; Bacterial; Parasite

• Related Pathways :

  Anti-infection

• Field of Research :

  Infection

• Purity :

  99.40

• Smiles :

  OCCN(CC1)CCN1CC/C=C2C3=CC(Cl)=CC=C3SC4=CC=CC=C4/2

• Molecular Formula :

  C22H25ClN2OS

• Molecular Weight :

  400.96

• References & Citations :

  [1]Kristiansen JE, et al. The susceptibility of Plasmodium falciparum in vitro to chlorpromazine and the stereo-isomeric compounds cis (Z) - and trans (E) -clopenthixol. Acta Pathol Microbiol Immunol Scand B. 1985 Jun;93 (3) :249-51.|[2]Kristiansen JE, et al. Stereo-isomeric dissociation of the antibacterial and the neuroleptic effect of clopenthixol. Acta Pathol Microbiol Scand B. 1981 Dec;89 (6) :437-8.

• Shipping Conditions :

  Room Temperature

• Storage Conditions :

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [53772-84-2]